METTL3 and hepatocellular carcinoma: Zuo et al. revealed that METTL3-mediated m6A modification promoted the stabilization of LINC00958, which sponged miR-3619-5p to upregulate hepatoma-derived growth factor (HDGF) and thereby facilitating HCC lipogenesis and progression [78].